PROEHL GERALD T (Pres., CEO and Chairman) received a stock award from DERMATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/23/2025ACC: 0001654954-25-000691
Officer10% Owner· Pres., CEO and Chairman
Since Aug 2021
+1.57M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.57M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+787.40K
Price / share
—
Trade value
—
% of position
6504.2%
1/21/2025
12.11K→799.51K
Total
Net shares
+787.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/21/2025 | A · Award | +787.40K | — | — | 6504.2% | 12.11K | 799.51K |
| Total | +787.40K | $0.00 | ||||||
Derivative Transactions1
Warrant (Right to Buy)
Indirect
Converts to
Common Stock
787.40K shares
Shares
+787.40K
Strike price
1.27
Held after
787.40K
Exercisable
—
1/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Indirect | Common Stock787.40K shares | 1/21/2025 | A · Award | +787.40K | 1.27 | — | 787.40K |
Non-Derivative Holdings (Post-Transaction)5
Common Stock
IndirectShares owned37.00
Common Stock
IndirectShares owned595.00
Common Stock
DirectShares owned247.00
Common Stock
IndirectShares owned149.00
Common Stock
IndirectShares owned74.00
Total
247.00 direct·855.00 indirect1.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 37.00 | Indirect |
| Common Stock | 595.00 | Indirect |
| Common Stock | 247.00 | Direct |
| Common Stock | 149.00 | Indirect |
| Common Stock | 74.00 | Indirect |
| Total | 1.10K | 247.00 direct·855.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported